347850 - D & D Pharmatech, Inc.

347850 Summary
Biopharma
Stock Price & Overview
₩49,200 +700 (+1.44%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩49,200  ≈ US$35  ·  Market cap ₩2.3tn (≈ $1.6bn)

347850 Stock Price

50K75K100Kprev 49Kpeak 111KOctNovDecJan ’26FebMarAprMayJunJulAugSep49K
52 Week Range
₩38,964₩111,200
Day Range
₩48,100₩49,800
Market Cap
₩2.3tn
P/E (TTM)
n/a (loss)
P/B
16.82x
P/S (TTM)
819.95x
Volume
424,756
Shares Out
45.8M
Prev. Close
₩48,500
vs 52W High
-55.8%
Multiples use the close and the financials that were public on that date (DART), the same series as the Valuation tab — they are not vendor figures.

347850 Analysis

See all »

Nothing written yet for this company.

347850 News

See all »

No news written yet.

347850 Momentum

Period347850KOSDAQDifference
1 week-11.5%-3.0%-8.5%
1 month-24.1%+4.2%-28.3%
3 months-47.7%-22.5%-25.2%
6 months-29.7%-16.9%-12.9%
Year to date-46.4%-12.1%-34.3%
1 year+26.3%+1.0%+25.3%

Closed at 14% of the way from its 52-week low (₩38,964) to its 52-week high (₩111,200).

Price return on KRX closes, KOSDAQ on the same dates, no dividends. A period starts at the last trading day on or before the calendar date.

347850 Filings

See all »
DART

Material matter affecting investment judgment (clinical trial result)

Filing08/21/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Single Supply Contract Signed

Contract07/14/26title translated
DART

Conversion rights exercised

Filing06/22/26title translated
Korean issuers file to DART, not the SEC. Titles are translated; where kstock has read the filing the row carries the explanation.

347850 Company Profile

D & D Pharmatech, Inc. does research and development in science and engineering in South Korea. It is listed on KOSDAQ, was founded in 2014, is based in Gyeonggi, and has revenue of under ten billion won.

SectorBiopharmaEmployees
MarketKOSDAQFounded2014
Korean name디앤디파마텍Head officeGyeonggi

Similar to 347850

SymbolLast Price
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
237690ST Pharm Co., Ltd.₩101,200
+2.2%
226950Olix Pharmaceuticals, Inc.₩95,900
+4.5%
140410Mezzion Pharma Co., Ltd.₩65,000
+0.0%
068760Celltrion Pharm, Inc.₩40,850
+0.0%
007390Naturecell Co., Ltd.₩23,950
+0.2%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.